This independent HPLC lab test confirms the blend (Cagrilintide 4.351mg, Semaglutide 5.182mg) from Empower Peptides at 99.82% total purity. The analysis was conducted by Freedom Diagnostics Testing on June 17, 2025.
Cagrilintide is an amylin analog researched for metabolic regulation and weight management, while Semaglutide is a GLP-1 receptor agonist with similar metabolic effects. Combined, these compounds target multiple pathways in glucose and appetite regulation. A purity level of 99.82% indicates high-grade synthesis with minimal impurities.
The full certificate of analysis is available for download on this page.

Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.